TY - JOUR AU - H Heerspink BT - The Lancet Diabetes and Endocrinology PY - 2020 SP - 582 EP - 593 T2 - The Lancet Diabetes and Endocrinology TI - Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial VL - 8 ER -